| Financial Year |
March 31 2023 |
| Monetary Funds |
253,260,502.48 |
| Held-for-trading Financial Assets |
30,701,845.49 |
| Notes Receivable |
239,718,091.18 |
| Accounts Receivable |
726,197,112.31 |
| Advances to Suppliers |
27,638,573.87 |
| Other Receivables |
8,832,932.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,176,564,626.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,759,193.61 |
| Total Current Assets |
2,505,398,968.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,211,519.74 |
| Investment Properties |
-- |
| Fixed Assetes |
1,780,452,147.06 |
| Under-construction Projects |
1,268,598.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
252,086,333.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
34,338,045.76 |
| Deferred Income Tax Assets |
39,498,775.83 |
| Other Non-Current Assets |
35,327,058.78 |
| Sub-Total of Non-Current Assets |
3,393,451,516.15 |
| Total Assets |
5,898,850,484.26 |
| Short-Term Loans |
233,190,727.05 |
| Trading Financial liabilities |
5,475,621.75 |
| Notes Payable |
174,569,653.97 |
| Accounts Payable |
515,355,392.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
103,857,510.13 |
| Taxes Payable |
24,892,230.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
172,850,058.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,039,860.43 |
| Other Current Liabilities |
56,894,820.40 |
| Sub-Total of Current Liabilities |
1,378,078,453.86 |
| Long-term Loans |
267,895,844.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,444,003.33 |
| Deferred Income Tax Liabilities |
51,401,317.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
440,872,596.21 |
| Total Liabilities |
1,818,951,050.06 |
| Paid-In Capital(Or Share Stock) |
383,486,298.00 |
| Capital Surplus |
989,402,040.24 |
| Surplus Reserve |
141,453,034.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,374,497,373.53 |
| Minority Stockholder's Interest |
189,344,173.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,890,555,260.37 |
| Owner's Equity（Stockholder's Equity） |
4,079,899,434.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,898,850,484.26 |
